Forward Citations = 45

Loading Chart...

3 inventors (with patents filed for the assignee):

Andrew C Hiatt (4 out of 31 patents)

Mich B Hein (4 out of 20 patents)

John H Fitchen (3 out of 8 patents)

4 patents: Sort by Forward Citations

1. 6696620 - Immunoglobulin binding protein arrays in eukaryotic cells (2004-02-24),

2. 6440419 - Epithelial cell targeting agent (2002-08-27),

3. 6391280 - J chain polypeptide targeting molecule linked to an imaging agent (2002-05-21),

4. 6045774 - J chain polypeptide targeting molecule linked to an imaging agent (2000-04-04),

Company Overview

Epicyte Pharmaceutical, Inc. is a leading biotechnology company specializing in the development of innovative therapies for a range of diseases. With a focus on cutting-edge research and advanced technologies, Epicyte is dedicated to improving patient outcomes and transforming the healthcare industry. Visit our website to learn more about our groundbreaking initiatives and impactful contributions to the field of medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1,008 in San Diego, CA

#14,058 in California

#60,671 in US

San Diego, CA, United States of America

Epicyte Pharmaceutical, Inc.

Forward Citations = 45

3 inventors:

Andrew C Hiatt (4 out of 31 patents)

Mich B Hein (4 out of 20 patents)

John H Fitchen (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epicyte Pharmaceutical, Inc.. Retrieved from https://idiyas.com/company/epicyte-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]